Business Description
Sinovac Biotech Ltd
NAICS : 325412
SIC : 2834
ISIN : AGP8696W1045
Compare
Compare
Traded in other countries / regions
SVQ.GermanySVA.USA IPO Date
2003-09-26Description
Sinovac Biotech Ltd is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state, and local levels. It sells its vaccines in China, while also exploring growth opportunities in international markets.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 42.06 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.33 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.96 | |||||
| Beneish M-Score | 1.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 80 | |||||
| 3-Year EBITDA Growth Rate | 32.2 | |||||
| 3-Year EPS without NRI Growth Rate | 34.6 | |||||
| 3-Year Book Growth Rate | 211.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.89 | |||||
| Quick Ratio | 9.74 | |||||
| Cash Ratio | 9.3 | |||||
| Days Inventory | 123.99 | |||||
| Days Sales Outstanding | 546.89 | |||||
| Days Payable | 230.87 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | -8.85 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -46.96 | |||||
| Operating Margin % | -358.35 | |||||
| Net Margin % | -84.05 | |||||
| ROE % | -3.92 | |||||
| ROA % | -2.47 | |||||
| ROIC % | -49.6 | |||||
| ROC (Joel Greenblatt) % | -69.67 | |||||
| ROCE % | -7.22 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 6.47 | |||||
| PE Ratio without NRI | 6.47 | |||||
| Shiller PE Ratio | 0.82 | |||||
| PEG Ratio | 0.09 | |||||
| PS Ratio | 1.76 | |||||
| PB Ratio | 0.07 | |||||
| Price-to-Tangible-Book | 0.07 | |||||
| EV-to-EBIT | 7.03 | |||||
| EV-to-EBITDA | 8.46 | |||||
| EV-to-Revenue | -16.09 | |||||
| EV-to-FCF | 30.86 | |||||
| Price-to-Projected-FCF | 0.02 | |||||
| Price-to-Median-PS-Value | 0.15 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.26 | |||||
| Price-to-Graham-Number | 0.14 | |||||
| Price-to-Net-Current-Asset-Value | 0.1 | |||||
| Price-to-Net-Cash | 0.11 | |||||
| Earnings Yield (Greenblatt) % | 14.22 | |||||
| Forward Rate of Return (Yacktman) % | 335.02 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SVA
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sinovac Biotech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 420.875 | ||
| EPS (TTM) ($) | 1 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 6.47 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 6.47 - 6.47 | ||
| Shares Outstanding (Mil) | 99.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sinovac Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sinovac Biotech Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sinovac Biotech Ltd Frequently Asked Questions
What is Sinovac Biotech Ltd(SVA)'s stock price today?
The current price of SVA is $6.47. The 52 week high of SVA is $6.47 and 52 week low is $6.47.
When is next earnings date of Sinovac Biotech Ltd(SVA)?
The next earnings date of Sinovac Biotech Ltd(SVA) is 2023-12-29 Est..
Does Sinovac Biotech Ltd(SVA) pay dividends? If so, how much?
Sinovac Biotech Ltd(SVA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers